Literature DB >> 7738582

Antiganglioside antibodies in the CSF of patients with motor neuron diseases and Guillain-Barré syndrome.

C Iñiguez, A Jiménez-Escrig, J M Gobernado, M Nocito, P Gonzalez-Porque.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7738582      PMCID： PMC1073463     

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Anti-GM1 IgM antibodies in motor neuron disease and neuropathy.

Authors:  E Nobile-Orazio; M Carpo; G Legname; N Meucci; S Sonnino; G Scarlato
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

2.  A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

Authors:  A Stevens; M Weller; H Wiethölter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

3.  Intrathecal immune response in patients with the post-polio syndrome.

Authors:  M K Sharief; R Hentges; M Ciardi
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

4.  Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups.

Authors:  A A Ilyas; R H Quarles; M C Dalakas; P H Fishman; R O Brady
Journal:  Ann Neurol       Date:  1985-12       Impact factor: 10.422

5.  Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.

Authors:  A Pestronk; R N Adams; L Clawson; D Cornblath; R W Kuncl; D Griffin; D B Drachman
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910
  5 in total
  1 in total

Review 1.  Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders.

Authors:  P Fredman; A Lekman
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.